Theratechnologies Announces Special Shareholder Meeting
| Field | Detail |
|---|---|
| Company | Theratechnologies Inc. |
| Form Type | 6-K |
| Filed Date | Jul 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance
TL;DR
Theratechnologies calling a special shareholder meeting July 18, 2025. Details to follow.
AI Summary
Theratechnologies Inc. filed a Form 6-K on July 18, 2025, to announce a Special Meeting of Shareholders. The meeting is scheduled for an upcoming date in July 2025, and details will be provided in a notice dated July 18, 2025.
Why It Matters
This filing indicates that Theratechnologies is convening its shareholders for a special meeting, suggesting important corporate decisions or proposals are on the agenda.
Risk Assessment
Risk Level: low — This is a routine filing announcing a shareholder meeting, with no immediate financial or operational risks disclosed.
Key Players & Entities
- Theratechnologies Inc. (company) — Registrant
- July 18, 2025 (date) — Filing date and notice date
- Jocelyn Lafond (person) — General Counsel and Corporate Secretary
FAQ
What is the purpose of the Special Meeting of Shareholders?
The filing does not specify the purpose of the Special Meeting of Shareholders, only that a notice was issued on July 18, 2025.
When is the Special Meeting of Shareholders scheduled to take place?
The filing indicates the meeting is for the month of July 2025, with a notice dated July 18, 2025, but a specific date for the meeting is not provided.
Who signed the Form 6-K filing?
The Form 6-K was signed by Jocelyn Lafond, General Counsel and Corporate Secretary of Theratechnologies Inc.
What is Theratechnologies Inc.'s principal executive office address?
Theratechnologies Inc.'s principal executive office is located at 2015 Peel Street, Suite 1100, Montreal, Quebec H3A 1T8, Canada.
What is Theratechnologies Inc.'s SIC code?
Theratechnologies Inc.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 18, 2025 by Jocelyn Lafond regarding Theratechnologies Inc..